At a median follow-up of 60.7 months, patients in the combination arm of enzalutamide + leuprolide had significantly superior 5-year metastasis free survival rates (87.3% versus 71.4%; HR: 0.42, 95% ...

Dr. Bryant Lin, who has stage 4 lung cancer, created a Stanford class that follows his journey, offering students an ...

Melanoma is the most prevalent cancer during pregnancy, representing 31% of all gestational cancers, and that number is ...

There is no cure; the best we can do is supportive care and try to limit some of the worst effects. So, please, if a child ...

The drug has been reported previously to cause neuropathy and hypersensitivity reactions in breast cancer patients.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...

Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials National estimates of cancer ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, was host to a State ...

Karla Flores was diagnosed with a rare brain tumor. A misplaced MRI found a second, nearly inoperable, tumor on her spine.

With timely intervention, doctors at AIIMS Delhi have been able to save the lives of nearly 70 to 80 per cent of ...

“The AI test has a negligible failure rate, while current genomic tests have a failure rate of 20% to 30%, necessitating ...